Archive: 13/06/2019
New biomarkers for cardiovascular risk in patients with juvenile-onset systemic lupus erythematosus (JSLE)
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) identify ApoB:A1 ratio and metabolomic lipoprotein signatures as potential biomarkers for cardiovascular risk in patients ...
Jun 13, 2019
New study debunks theoretical risks of live-attenuated vaccines in children with rheumatic diseases
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019), jointly organised with the Paediatric Rheumatology Society (PReS), demonstrate no vaccine infections, and no disease flare, ...
Jun 13, 2019
Patients at a reduced risk of venous thromboembolism and persistent pain after partial versus total knee replacement
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate reduced risk of venous thromboembolism and persistent pain, but increased risk of revision in partial versus ...
Jun 13, 2019
Verinurad with febuxostat significantly reduces albuminuria and hyperuricaemia in patients with type 2 diabetes
The results of a phase IIa clinical trial presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate a rapid reduction in albuminuria and hyperuricaemia in patients with type II diabetes with ...
Jun 13, 2019
War, depression, suicide: American veterans are finding help
Roger King was 19 when he enlisted in the US Marine Corps in 2005. He left four years later after two deployments in Iraq, where a sniper's bullet nearly cost him his life.
Jun 13, 2019
No link between cancer and tumor necrosis factor inhibitor (TNFi) use in psoriatic arthritis
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) suggest that overall cancer risk is not linked to tumour necrosis factor inhibitor (TNFi) use in psoriatic arthritis.
Jun 13, 2019
Study supports bisphosphonate use prior to denosumab to prevent loss of bone mineral density in post-menopausal women
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) finds the risk of bone mineral density (BMD) loss after denosumab discontinuation is associated with younger age, high bone ...
Jun 13, 2019